As the market begins today, shares of NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) seem to be continuing their prior session’s gain, propelled by news of recent
On March 18, NeuroBo Pharmaceuticals Inc. (NRBO) stock surged up in the after-hours while there is no news from the company. The latest news from
NeuroBo Pharmaceuticals, Inc. (NRBO) is a leading innovative biotherapeutics company engaged in the development of treatments for neuropathic and neurodegenerative diseases. One of the lead
NeuroBo Pharmaceuticals Inc. (NRBO) shares surged 41.49% in after-hours on Monday, July 19, 2021, and closed at $3.99 per share. Earlier in the morning session,
Shares of NeuroBo Pharmaceuticals Inc. (NRBO), a clinical-stage biotechnology company that provides therapies for neurodegenerative and cardiometabolic diseases, dropped by 10.89% on Friday. The company
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.